Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6619 USD | +2.52% | -0.26% | -11.23% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.23% | 13.61M | |
+28.95% | 48.16B | |
-0.40% | 41.73B | |
+43.57% | 41.03B | |
-5.31% | 28.77B | |
+10.77% | 25.59B | |
-21.84% | 18.96B | |
+8.48% | 12.92B | |
+27.48% | 12.03B | |
-2.76% | 11.77B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Earnings Flash (ONTX) ONCONOVA THERAPEUTICS Reports Q2 Revenue $57,000, vs. Street Est of $0.07M